How total abortion ban puts maternal health at risk
Pregnant patients in El Salvador, who, under the nation’s abortion ban, had no choice but to carry fetuses with severe […]
Feeling funny? Natalie Dattilo says that’s a good thing. The former director of psychology at Brigham and Women’s Hospital says […] A new study that analyzed the tumor microenvironment of pancreatic cancer revealed the cause of tumor cell resistance to immunotherapy […] WASHINGTON (Reuters) – Canadian Prime Minister Justin Trudeau said on Wednesday he had invited the premiers from all provinces to […] A new study from researchers at Indiana University School of Public Health-Bloomington has found that adding one ounce of walnuts […] https://www.youtube.com/embed/HF3GQIzZSSM Some 706 children received immunoglobulin medicine for Kawasaki disease in 2020/21, compared to an average of 336 per year […] Adults living in rural areas of the United States have a 19% higher risk of developing heart failure compared to […] Approximately half of people with type 1 or type 2 diabetes experience peripheral neuropathy—weakness, numbness, and pain, primarily in the […] More than half of patients with testicular cancer treated with first-line cisplatin-based chemotherapy in a recent study developed hearing loss […] In a recent study posted to bioRxiv*, researchers reported that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB.1.5 […]Health News
A laugh a day keeps the doctor away?
Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
Trudeau to Hold Health Care Meeting With Premiers of Canadian Provinces
Adding one handful of walnuts to the diet can provide good nutrition
NHS appeal for plasma donors after jump in kids with deadly disease
Study finds rural residents have 19% higher risk of heart failure than their urban counterparts
Supplementation with amino acid serine eases neuropathy in diabetic mice
Routine Tests for Hearing Loss in All Cisplatin-Treated Patients
Data demonstrates SARS-CoV-2 Omicron XBB.1.5 substantially escapes NAb responses after bivalent mRNA boosting